Tennessee Valley Asset Management Partners Amgen Inc Transaction History

Tennessee Valley Asset Management Partners

  • $610 Million
  • Q3 2024

A detailed history of Tennessee Valley Asset Management Partners transactions in Amgen Inc stock. As of the latest transaction made, Tennessee Valley Asset Management Partners holds 626 shares of AMGN stock, worth $175,323. This represents 0.03% of its overall portfolio holdings.

Number of Shares
626
Holding current value
$175,323
% of portfolio
0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$309.38 - $337.38 $193,671 - $211,199
626 New
626 $201,000
Q4 2023

Jan 29, 2024
BUY
$255.7 - $288.46 $70,317 - $79,326
275 New
275 $79,000
Q2 2021

Jul 26, 2021
SELL
$233.58 - $259.14 $369,523 - $409,959
-1,582 Closed
0 $0
Q1 2021

Apr 16, 2021
SELL
$221.91 - $258.6 $16,865 - $19,653
-76 Reduced 4.58%
1,582 $393,000
Q4 2020

Feb 02, 2021
BUY
$216.38 - $257.67 $172,022 - $204,847
795 Added 92.12%
1,658 $381,000
Q3 2020

Oct 21, 2020
SELL
$234.65 - $260.95 $7,039 - $7,828
-30 Reduced 3.36%
863 $219,000
Q2 2020

Nov 05, 2020
BUY
$197.81 - $242.74 $176,644 - $216,766
893 New
893 $211,000
Q1 2020

Nov 12, 2020
SELL
$182.24 - $241.7 $197,001 - $261,277
-1,081 Closed
0 $0
Q4 2019

Nov 12, 2020
SELL
$189.21 - $243.2 $3,784 - $4,864
-20 Reduced 1.82%
1,081 $261,000
Q3 2019

Nov 12, 2020
BUY
$174.11 - $208.62 $1,044 - $1,251
6 Added 0.55%
1,101 $213,000
Q2 2019

Nov 12, 2020
BUY
$166.7 - $195.41 $182,536 - $213,973
1,095 New
1,095 $202,000
Q1 2019

Nov 12, 2020
SELL
$180.87 - $203.88 $190,275 - $214,481
-1,052 Closed
0 $0
Q4 2018

Nov 12, 2020
BUY
$178.4 - $208.25 $187,676 - $219,079
1,052 New
1,052 $205,000

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tennessee Valley Asset Management Partners Portfolio

Follow Tennessee Valley Asset Management Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tennessee Valley Asset Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Tennessee Valley Asset Management Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email